Lindsay Kelmenson is a Rheumatology/Immunology physician affiliated with University of Colorado Anschutz Medical Campus. OpenAlex indexes 12 publications with 1,173 citations (h-index 10); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5356 Stadium Trace Pkwy Ste 200
Hoover, AL 352445610
Telephone
205-444-4858Provider last certified this registry record 15 Jun 2021.
Clinical trials
- Periodontal Inflammation and Immunity in Preclinical Rheumatoid Arthritis
Sponsor: University of Colorado, Denver
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
37 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year202547 payments
- ABBVIE INC.Program year202525 payments
- PFIZER INC.Program year202517 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
56.7%Selective T Cell Costimulation Modulator54.5%Abatacept100%Orencia Clickject0%Part D + Part B<11 patientsFolate Analog Metabolic Inhibitor0.9%Methotrexate100%Part D≥36 patients+ 6 more classes in this area
Musculoskeletal
26.9%RANK Ligand Inhibitor25.6%Denosumab100%Part B, office-administered≥47 patientsMuscle Relaxant0.5%Cyclobenzaprine Hcl75%Methocarbamol25%Part D<11 patients+ 4 more classes in this area
Dermatology
9.8%Corticosteroid9.8%Methylprednisolone acetate63%Methylprednisolone sodium succinate35%Triamcinolone Acetonide1%Methylprednisolone1%Part D + Part B≥21 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Oral mucosal breaks trigger anti-citrullinated bacterial and human protein antibody responses in rheumatoid arthritis
Science Translational Medicine
2023 - Serum antibodies to periodontal pathogens prior to rheumatoid arthritis diagnosis: A case-control study
Seminars in Arthritis and Rheumatism
2023 - Circulating blood metabolite trajectories and risk of rheumatoid arthritis among military personnel in the Department of Defense Biorepository
Annals of the Rheumatic Diseases
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Richard Schulick, MD, MBA
University of Colorado Anschutz Medical Campus
John Rumsfeld, MD, PhD
University of Colorado Anschutz Medical Campus
Robert Eckel, MD
University of Colorado Anschutz Medical Campus
Marc Bonaca, MD
University of Colorado Anschutz Medical Campus
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”